. .
Français
France
Livres similaires
Autres livres qui pourraient ressembler au livre recherché:
Outils de recherche
s'inscrire

Connectez-vous avec Facebook:

S'inscrire
Mot de passe oublié?


Historique de recherche
Liste pense-bête
Liens vers eurolivre.fr

Partager ce livre sur…
Livre conseillé
Actualités
Conseils d'eurolivre.fr
Publicité
FILTRE
- 0 Résultats
prix le plus bas: 197,94 €, prix le plus élevé: 245,03 €, prix moyen: 235,61 €
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Livre non disponible
(*)
Ingo K. Mellinghoff:
Therapeutic Kinase Inhibitors - nouveau livre

ISBN: 9783642282959

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert., [SC: 0.00], Neuware, gewerbliches Angebot, 242x165x23 mm, [GW: 492g]

Nouveaux livres Booklooker.de
Carl Hübscher GmbH
Frais d'envoiVersandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Livre non disponible
(*)
Ingo K. Mellinghoff:
Therapeutic Kinase Inhibitors - nouveau livre

ISBN: 9783642282959

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert., [SC: 0.00], Neuware, gewerbliches Angebot, FixedPrice, [GW: 492g]

Nouveaux livres Booklooker.de
Buchhandlung Kühn GmbH
Frais d'envoiVersandkostenfrei, Versand nach Deutschland (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff
Livre non disponible
(*)
Ingo K. Mellinghoff:
Therapeutic Kinase Inhibitors - nouveau livre

22, ISBN: 9783642282959

[ED: Buch], [PU: Springer-Verlag GmbH], Neuware - Cancer drug development is currently undergoing a profound shift. Drugs targeting fundamental cellular processes such DNA-replication and microtubule function, often referred to as 'chemotherapy' and still the backbone of most cancer treatment regimens, are increasingly being complemented by or replaced with kinase inhibitors. This new class of drugs targets enzymes which provide growth and survival signals to cancer cells by transferring phosphate groups from Adenosine-5'-triphosphate (ATP) to other proteins, lipids, nucleotides, and carbohydrates. This book summarizes the current state of kinase inhibitor therapy for cancer. Successful drug development relies on the expertise and dedication of many experts. To reflect this team approach to finding new kinase inhibitors and defining their optimal use for cancer treatment, the editorsinvited experts in academia and pharmaceutical industry to share their insights into various aspects of this process, ranging from the first chemical screens, to preclinical testing and disease-focused clinical drug development. The editors and authorshope these lessons will be instructive for the novice as well as the expert., [SC: 2.00]

Nouveaux livres Booklooker.de
buchversandmimpf2000
Frais d'envoi EUR 2.00
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff; Charles L. Sawyers
Livre non disponible
(*)
Ingo K. Mellinghoff; Charles L. Sawyers:
Therapeutic Kinase Inhibitors - nouveau livre

ISBN: 9783642282959

ID: 9783642282959

Biomedicine; Cancer Research Mitogen Activated Protein Kinase (MAPK), Raf kinases, biomarkers, chemical library, clinical trial design, drug development, drug efficacy, epigenetics, gastrointestinal stromal tumor (GIST), genetically engineered mouse models (GEMMs), glioblastoma, lung adenocarcinoma, lung cancer, melanoma, myeloproliferative neoplasms, small molecules Books Book, Springer Science+Business Media

Nouveaux livres Springer.com
Frais d'envoi EUR 0.00
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.
Therapeutic Kinase Inhibitors - Ingo K. Mellinghoff; Charles L. Sawyers
Livre non disponible
(*)
Ingo K. Mellinghoff; Charles L. Sawyers:
Therapeutic Kinase Inhibitors - edition reliée, livre de poche

2012, ISBN: 9783642282959

ID: 22428658

2012, Hardcover, Buch, [PU: Springer Berlin]

Nouveaux livres Lehmanns.de
Frais d'envoiVersand in 7-9 Tagen, , Versandkostenfrei innerhalb der BRD (EUR 0.00)
Details...
(*) Livre non disponible signifie que le livre est actuellement pas disponible à l'une des plates-formes associées nous recherche.

Détails sur le livre
Therapeutic Kinase Inhibitors
Auteur:

Ingo K. Mellinghoff

Titre:

Therapeutic Kinase Inhibitors

ISBN:

Informations détaillées sur le livre - Therapeutic Kinase Inhibitors


EAN (ISBN-13): 9783642282959
ISBN (ISBN-10): 3642282954
Version reliée
Date de parution: 2012
Editeur: Springer-Verlag GmbH
234 Pages
Poids: 0,492 kg
Langue: Englisch

Livre dans la base de données depuis 22.02.2007 17:09:48
Livre trouvé récemment le 07.03.2017 22:11:21
ISBN/EAN: 3642282954

ISBN - Autres types d'écriture:
3-642-28295-4, 978-3-642-28295-9


< pour archiver...
Livres en relation